INIS
reviews
100%
diabetes mellitus
100%
medicine
72%
india
55%
drugs
50%
inflammation
50%
rats
50%
glucose
40%
diet
35%
tissues
33%
blood
32%
evaluation
29%
standardization
27%
doses
27%
concentration
27%
injuries
25%
plasma
25%
statistics
25%
fats
25%
pregnancy
25%
sugar
25%
angiotensin
25%
slip
25%
prisms
25%
hospitals
25%
learning
25%
equipment
25%
liberins
25%
enzymes
25%
in vitro
25%
proteins
25%
sheep
25%
toxicity
25%
weight
25%
hplc
25%
stability
25%
storage life
25%
diseases
24%
lipids
22%
people
20%
healing
20%
data
19%
screening
19%
liver
19%
patients
17%
comparative evaluations
17%
males
16%
reduction
16%
increasing
14%
diagnosis
12%
Medicine and Dentistry
Ayurveda
86%
Medicine
52%
Maturity Onset Diabetes of the Young
50%
Disease
34%
Systematic Review
28%
Complementary and Alternative Medicine
25%
Ayurvedic Drug
25%
Tertiary Care
25%
Meta-Analysis
25%
Glycon
25%
Injury
25%
Health Promotion
25%
Mental Health
25%
Diabetes Mellitus
25%
Antiinflammatory Activity
25%
Hyperlipidemia
25%
Dyslipidemia
25%
Diet Induced Obesity
25%
High Fat Food
25%
Blood Glucose
15%
Diagnosis
12%
Student T Test
12%
McNemar Test
12%
Attitude
12%
Health Care Provider
12%
Anamnesis
12%
Laboratory Test
12%
Physical Examination
12%
Obstetrics
12%
Medical Device
12%
Medical Statistics
12%
Healing Touch
12%
Vascular Cell Adhesion Molecule 1
10%
Artery
10%
C Reactive Protein
8%
Pregnancy
6%
Yoga
6%
Perinatal Period
6%
Randomized Controlled Trial
6%
Prenatal Period
6%
Fertilization
6%
Progeny
6%
Birth
6%
Nutrition
6%
Bone Disease
5%
Enzyme Linked Immunosorbent Assay
5%
Hyperglycemia
5%
Hypolipemia
5%
Antidiabetic Agent
5%
Histopathology
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
58%
Metformin
35%
Antidiabetic Agent
34%
Ayurvedic Drug
25%
Chronic Toxicity
25%
Injury
25%
Dipeptidyl Carboxypeptidase
25%
Cuprous Ion
25%
Cinnamomum zeylanicum
25%
Domestic Sheep
25%
Hyperlipidemia
25%
Antiinflammatory Activity
25%
Dyslipidemia
25%
Diet Induced Obesity
25%
Beta Asarone
25%
Reverse Phase High Performance Liquid Chromatography
25%
Wistar Rat
13%
High Performance Liquid Chromatography
12%
Vascular Cell Adhesion Molecule 1
10%
Glycosylated Hemoglobin
10%
Clinical Trial
10%
Placebo
9%
Inflammation
9%
C Reactive Protein
8%
Chronic Toxicity Study
8%
Adverse Event
8%
Bovine Serum Albumin
7%
Cardiovascular Disease
6%
Morbidity
5%
Skin Disease
5%
Enzyme-Linked Immunosorbent Assay
5%
Hyperglycemia
5%
Disease
5%
Bone Disease
5%
Triacylglycerol
5%
Randomized Controlled Trial
5%
Mortality Rate
5%
Hypolipemia
5%